Bavarian Nordic seeks EMA nod for Mpox vaccine in children aged 2–11
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
Doctors at the hospital highlighted that robotic-assisted surgery enhances precision through superior 3D visualisation and improved instrument flexibility
It promises fewer injections for vision loss patients
Call it a major breakthrough for diagnostic imaging
The company plans to submit the vaccine for regulatory review
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Subscribe To Our Newsletter & Stay Updated